Carol Gallagher

New Enterprise Associates Partner

San Diego, California
$200k - $40.0m
$10.0m
CompanyDeal TypeAmountDate
Pionyr ImmunotherapeuticsSeries B$62M (Lead)Dec 2017
MetacrineSeries B$22M (Lead)Dec 2017
Good2GoSeed Round$7MSep 2017
Good2Go, Inc.Seed Round$7MSep 2017
Cleave BiosciencesSeries B$37M (Lead)Aug 2016
Millendo TherapeuticsSeries B$62M (Lead)Jan 2016
Cleave BiosciencesSeries A$10MApr 2013
No media found for Carol Gallagher. Add it now.

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb

New Enterprise Associates

AL

New Enterprise Associates

AB

New Enterprise Associates

AM

New Enterprise Associates

AS

New Enterprise Associates